• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Therapeutic trials with VP-16-213 and VM-26: active agents in small cell lung cancer, non-Hodgkin's lymphomas, and other malignancies.

作者信息

Radice P A, Bunn P A, Ihde D C

出版信息

Cancer Treat Rep. 1979 Aug;63(8):1231-9.

PMID:225026
Abstract
摘要

相似文献

1
Therapeutic trials with VP-16-213 and VM-26: active agents in small cell lung cancer, non-Hodgkin's lymphomas, and other malignancies.
Cancer Treat Rep. 1979 Aug;63(8):1231-9.
2
Etoposide (VP-16-213). Current status of an active anticancer drug.依托泊苷（VP - 16 - 213）。一种活性抗癌药物的现状。
N Engl J Med. 1985 Mar 14;312(11):692-700. doi: 10.1056/NEJM198503143121106.
3
Treatment strategies in relation to drug action.与药物作用相关的治疗策略。
NCI Monogr. 1987(4):129-33.
4
[New antineoplastic drugs of the podophyllotoxin derivative group].[鬼臼毒素衍生物类新型抗肿瘤药物]
Pol Tyg Lek. 1983 Jan 3;38(1):27-30.
5
[Phase II study of NK 171 (etoposide) on malignant lymphomas and acute leukemia. A cooperative study group on NK 171 in hematological malignancies].NK 171（依托泊苷）治疗恶性淋巴瘤和急性白血病的II期研究。血液系统恶性肿瘤NK 171合作研究组
Gan To Kagaku Ryoho. 1986 Mar;13(3 Pt 1):496-501.
6
[Phase II study of etoposide (NK 171) in advanced hematological malignancies].依托泊苷（NK 171）用于晚期血液系统恶性肿瘤的II期研究
Gan To Kagaku Ryoho. 1984 Aug;11(8):1579-84.
7
Phase II clinical trial of weekly administration of VP-16-213 in small cell bronchogenic carcinoma.
Cancer Treat Rep. 1977 May-Jun;61(3):489-90.
8
[A phase II study of intravenous VP-16-213 in small cell and non-small cell carcinoma of the lung].
Gan To Kagaku Ryoho. 1986 Apr;13(4 Pt 1):931-7.
9
Multicenter Phase II trial of etoposide in refractory small cell lung cancer.
Cancer Treat Rep. 1985 Jan;69(1):127-8.
10
[A phase II study of etoposide (VP-16) injection in primary lung cancer by cooperative study group].
Gan To Kagaku Ryoho. 1986 Jan;13(1):116-21.

引用本文的文献

1
Targeting EMT using low-dose Teniposide by downregulating ZEB2-driven activation of RNA polymerase I in breast cancer.通过下调 ZEB2 驱动的 RNA 聚合酶 I 激活来低剂量依托泊苷靶向 EMT 治疗乳腺癌。
Cell Death Dis. 2024 May 8;15(5):322. doi: 10.1038/s41419-024-06694-7.
2
Overcoming multiple drug resistance mechanisms in medulloblastoma.克服髓母细胞瘤中的多种耐药机制。
Acta Neuropathol Commun. 2014 May 30;2:57. doi: 10.1186/2051-5960-2-57.
3
Primary WWOX phosphorylation and JNK activation during etoposide induces cytotoxicity in HEK293 cells.
依托泊苷诱导 HEK293 细胞毒性过程中 WW0X 的初步磷酸化和 JNK 的激活。
Daru. 2010;18(2):141-5.
4
Inhibition of CYP3A4 and CYP2C9 by podophyllotoxin: implication for clinical drug-drug interactions.鬼臼毒素对 CYP3A4 和 CYP2C9 的抑制作用：对临床药物相互作用的影响。
J Biosci. 2011 Dec;36(5):879-85. doi: 10.1007/s12038-011-9143-9.
5
Pharmacokinetic optimisation of treatment with oral etoposide.口服依托泊苷治疗的药代动力学优化
Clin Pharmacokinet. 2004;43(7):441-66. doi: 10.2165/00003088-200443070-00002.
6
Cisplatin and etoposide in oesophageal cancer: a phase II study. Rotterdam Oesophageal Tumour Study Group.顺铂和依托泊苷用于食管癌治疗：一项II期研究。鹿特丹食管癌研究组
Br J Cancer. 1996 Sep;74(6):980-4. doi: 10.1038/bjc.1996.469.
7
Therapeutic drug monitoring in 21-day oral etoposide treatment for lung cancer.21天口服依托泊苷治疗肺癌的治疗药物监测
Jpn J Cancer Res. 1996 Aug;87(8):856-61. doi: 10.1111/j.1349-7006.1996.tb02111.x.
8
Phase II study of prolonged oral therapy with etoposide (VP16) for patients with recurrent malignant glioma.依托泊苷（VP16）长期口服治疗复发性恶性胶质瘤患者的II期研究。
J Neurooncol. 1996 Feb;27(2):149-55. doi: 10.1007/BF00177478.
9
Therapeutic drug monitoring of etoposide in a 14-day infusion for non-small-cell lung cancer.依托泊苷在非小细胞肺癌14天输注治疗中的治疗药物监测
Jpn J Cancer Res. 1996 Feb;87(2):200-5. doi: 10.1111/j.1349-7006.1996.tb03159.x.
10
Cytotoxic properties of a new synthetic demethylpodophyllotoxin derivative, BN 58705, against human tumor cell lines.一种新型合成去甲基鬼臼毒素衍生物BN 58705对人肿瘤细胞系的细胞毒性特性
Cancer Chemother Pharmacol. 1993;32(4):293-300. doi: 10.1007/BF00686175.